BXBocheng Xu

Bocheng Xu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Bocheng Xu has a total of 34 co-authors. Here are the top co-authors by number of shared publications:

  • Lin Wang

    National Engineering Research Center for Green Feed and Healthy Breeding, Key Laboratory of Molecular Animal Nutrition, Ministry of Education, Key Laboratory of Animal Nutrition and Feed Science (Eastern of China), Ministry of Agriculture and Rural Affairs, Key Laboratory of Animal Feed and Nutrition of Zhejiang Province, Institute of Feed Science, Zhejiang University, Hangzhou 310058, China

    2 shared publications
  • Yizhen Wang

    College of Animal Sciences, Zhejiang University, Hangzhou 310058, China

    2 shared publications
  • Aowen Wang

    College of Computer Science and Technology, Zhejiang University, Hangzhou, China

    1 shared publication
  • Chen Yang

    Center for Drug Safety Evaluation and Research, Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310007, China

    1 shared publication
  • Chen Yang

    Center for Drug Safety Evaluation and Research, Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310007, China

    1 shared publication
  • Cong Wang

    MOE Key Laboratory of Macromolecule Synthesis and Functionalization, Department of Polymer Science and Engineering, Zhejiang University, Hangzhou, PR China

    1 shared publication

Latest Publications

  • Open Access

    Iterative discovery of potent polymeric antibiotics via multi-stage and multi-task learning against antimicrobial resistance

    by Yuhui Wu, Cong Wang, Xintian Shen, Yan Chen, Haiping Wang, Bocheng Xu, Zihao Zhu, Yifeng Chen, Wenbin Dai, Yue Huang, et al.

    Drug-resistant bacterial infections pose a serious threat to global health, driving the development of antibacterial strategies beyond classic antibiotics. Host defense peptide mimetic polymeric antibiotics have emerged as promising candidates to combat drug resistance, however, navigating the vast chemical space of polymers remains a significant challenge due to complex structure–activity relationships, while data-driven approaches are further constrained by polymer complexity and scarce labeled data. To address this, we develop PolyCLOVER, a framework that integrates multi-stage self-supervised learning, active learning, and high-throughput experimentation to iteratively discover polymeric antibiotics with potent antibacterial activity and low toxicity. Applied to a combinatorial library of ~100,000 poly(β-amino ester)s, the framework uncovers three lead compounds that self-assemble into stable nanoparticles (SANPs) with minimum inhibitory concentrations of 4 μg/mL and 8 μg/mL against multidrug-resistant S. aureus and A. baumannii, respectively. These SANPs also serve as adjuvant antibiotic carriers, restoring bacterial sensitivity to penicillin G. In vivo studies demonstrate their therapeutic efficacy both as monotherapies and in combination therapies with antibiotics. PolyCLOVER may become a powerful framework for discovery of new polymeric biomaterials without reliance on external datasets.


  • Open Access

    Omnireg-gpt: a high-efficiency foundation model for comprehensive genomic sequence understanding

    by Aowen Wang, Jiaqi Li, Hongyu Dong, Bocheng Xu, Qingyu Yin, Yanchao Xu, Jie Fu, Junbo Zhao

    The human genome contains a sophisticated array of elements that regulate gene activity and organismal functions. Developing a large window foundation model capable of efficiently processing long sequence inputs is essential yet challenging for decoding the multi-layered and complex landscape of the cis-regulatory elements. Here, we introduce OmniReg-GPT, a generative foundation model designed for the low-resource pretraining of long genomic sequences by optimized attention mechanism. During pretraining, OmniReg-GPT captures the complete distribution of regulatory elements across nucleotide to megabase scales with efficient training speed and memory usage. We demonstrate exceptional performance in downstream regulotary applications spanning the entire spectrum of genomic scales, including various cis-regulatory elements identification, context dependent gene expression prediction, single-cell chromatin accessibility analysis, and 3D chromatin contact modeling. As a generative model, OmniReg-GPT also holds the potential to generate candidate cell-type-specific enhancers through prompt engineering. Overall, OmniReg-GPT extends the boundaries of foundation models in the genomic field, and provides a valuable pretraining model resource which can be extensively applied for genomic researches.


  • Open Access

    Specifically targeted antimicrobial peptides synergize with bacterial-entrapping peptide against systemic MRSA infections

    by Bocheng Xu, Lin Wang, Chen Yang, Rong Yan, Pan Zhang, Mingliang Jin, Huahua Du, Yizhen Wang


  • Open Access

    Gut-targeted nanoparticles deliver specifically targeted antimicrobial peptides against Clostridium perfringens infections

    by Bocheng Xu, Weike Shaoyong, Lin Wang, Chen Yang, Tingjun Chen, Xiao Jiang, Rong Yan, Zipeng Jiang, Pan Zhang, Mingliang Jin, et al.

    Specifically targeted antimicrobial peptides (STAMPs) are novel alternatives to antibiotics, whereas the development of STAMPs for colonic infections is hindered by limited de novo design efficiency and colonic bioavailability. In this study, we report an efficient de novo STAMP design strategy that combines a traversal design, machine learning model, and phage display technology to identify STAMPs against Clostridium perfringens . STAMPs could physically damage C. perfringens , eliminate biofilms, and self-assemble into nanoparticles to entrap pathogens. Further, a gut-targeted engineering particle vaccine (EPV) was used for STAMPs delivery. In vivo studies showed that both STAMP and EPV@STAMP effectively limited C. perfringens infections and then reduced inflammatory response. Notably, EPV@STAMP exhibited stronger protection against colonic infections than STAMPs alone. Moreover, 16 S ribosomal RNA sequencing showed that both STAMPs and EPV@STAMP facilitated the recovery of disturbed gut microflora. Collectively, our work may accelerate the development of the discovery and delivery of precise antimicrobials.